Use of the harmonic mean to the determination of dissociation constants of stereoisomeric mixtures of biologically active compounds

References

• Shimazawa R, Nagai N, Toyoshima S, Okuda H. Present state of new chiral drug development and review in Japan. J Health Sci 2008;54:23–9
   Web of Science ®Google Scholar
• McConathy J, Owens MJ. Stereochemistry in drug action. Prim Care Companion J Clin Psychiatry 2003;5:70–3
   PubMedGoogle Scholar
• Nguyen LA, He H, Pham-Huy C. Chiral drugs. An overview. Int J Biomed Sci 2006;2:85–100
   PubMedGoogle Scholar
• Lien EJ. Chirality and drug targeting: Pros and Cons. J Drug Target 1995;2:527–32
   PubMed Web of Science ®Google Scholar
• Hutt AJ, Valentová J. The chiral switch: the development of single enantiomer drugs from racemates. Acta Facult Pharm Univ Comenianae 2003;50:7–23
   Google Scholar
• Waldeck B. Three-dimensional pharmacology, a subject ranging from ignorance to overstatements. Pharmacol Toxicol 2003;93:203–10
   PubMedGoogle Scholar
• Smith SW. Chiral toxicology: it’s the same thing…only different. Toxicol Sci 2009;110:4–30
   PubMed Web of Science ®Google Scholar
• Copeland RA. Enzymes: a practical introduction to structure, mechanism and data analysis. New York: John Wiley & Sons. Inc; 2000:76–8
   Google Scholar
• Marques de Cantú MJ. Probabilidad y estadística para ciencias químico-biológicas. México DF: McGraw-Hill Interamericana; 1991:192–3
   Google Scholar
• Smyth HF, Weil CS, Wets JS, Carpeter CP. An exploration of joint toxic action: twenty-seven industrial chemical intubated in rats in all possible pairs. Toxicol Appl Pharmacol 1969;14:340–7
   PubMed Web of Science ®Google Scholar
• Hoel DG. Statistical aspects of chemical mixtures. In: Vouk VB, Butler GC, Upton AC, et al., eds. Methods for assessing the effects of mixtures of chemicals. Great Britain: John Wiley & Sons. Inc; 1987:369–77
   Google Scholar
• Raffa RB. Harmonic mean relationship between affinity for wild-type receptors and alanine-scan mutants. J Theor Biol 2002;218:207–14
   PubMed Web of Science ®Google Scholar
• Chou TC, Talalay P. Generalized equations for the analysis of inhibitions of Michaelis-Menten and higher-order kinetic systems with two or more mutually exclusive and nonexclusive inhibitors. Eur J Biochem 1981;115:207–16
   PubMedGoogle Scholar
• Santos RG, Giulianotti MA, Dooley CT, et al. The use and implications of the harmonic mean model on mixtures for basic research and drug discovery. ACS Comb Sci 2011;13:337–44
   PubMed Web of Science ®Google Scholar
• Bellemann P, Schade A, Towart R. Dihydropiridine receptor in rat brain labeled with [3H]nimodipine. Proc Natl Acad Sci U S A 1983;80:2356–60
   PubMed Web of Science ®Google Scholar
• Maan AC, Hosey MM. Analysis of the properties of binding of calcium-channel activators and inhibitors to dihydropiridine receptors in chick heart membranes. Circ Res 1987;61:379–88
   PubMed Web of Science ®Google Scholar
• Wahlund G, Nerme V, Abrahamsson T, Sjöquist P-O. The β1- and β2-adrenoceptor affinity and β1-blocking potency of S- and R-metoprolol. Br J Pharmacol 1990;99:592–6
   PubMed Web of Science ®Google Scholar
• Walle UK, Pesola GR, Walle T. Stereoselective sulphate conjugation of salbutamol in humans: comparison of hepatic, intestinal and platelet activity. Br J Clin Pharmacol 1993;35:413–18
   PubMed Web of Science ®Google Scholar
• Meng F, Xie G-X, Thompson RC, et al. Cloning and pharmacological characterization of a rat κ opioid receptor. Proc Natl Acad Sci U S A 1993;90:9954–8
   PubMed Web of Science ®Google Scholar
• Chen Y, Mestek A, Liu J, Yu L. Molecular cloning of a rat κ opioid receptor reveals sequence similarities to the µ and δ opioid receptors. Biochem J 1993;295:625–8
   PubMed Web of Science ®Google Scholar
• Guard S, Boyle SJ, Tang KW, et al. The interaction of the NK1 receptor antagonist CP-96,345 with L-type calcium channels and its functional consequences. Br J Pharmacol 1993;110:385–91
   PubMed Web of Science ®Google Scholar
• Yang T, Prakash C, Roden DM, Snyders DJ. Mechanism of block of a human cardiac potassium channel by terfenadine racemate and enantiomers. Br J Pharmacol 1995;115:267–74
   PubMed Web of Science ®Google Scholar
• Lejeune F, Newman-Tancredi A, Audinot V, Millan MJ. Interactions of (+)- and (–)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurons in rats. J Pharmacol Exp Ther 1997;280:1241–9
   PubMed Web of Science ®Google Scholar
• Hirota K, Okawa H, Appadu BL, et al. Stereoselective interaction of ketamine with recombinant µ, κ and δ opioid receptors expressed in Chinese hamster ovary cells. Anesthesiology 1999;90:174–82
   PubMed Web of Science ®Google Scholar
• Sun J, Meyers MJ, Fink BE, et al. Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-α or estrogen receptor-β. Endocrinology 1999;140:800–4
   PubMed Web of Science ®Google Scholar
• Rothman RB, Baumann MH, Savage JE, et al. Evidence for possible involvement of 5-HT2B receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications. Circulation 2000;102:2836–41
   PubMed Web of Science ®Google Scholar
• Gillard M, Van der Perren C, Moguilevsky N, et al. Binding characteristics of cetirizine and levocetirizine to human H1 histamine receptors: contribution of Lys191 and Thr194. Mol Pharmacol 2002;61:391–9
   PubMed Web of Science ®Google Scholar
• Booth RG, Moniri NH, Bakker RA, et al. A Novel Phenylaminotetralin radioligand reveals a subpopulation of histamine H1 receptors. J Pharmacol Exp Ther 2002;302:328–36
   PubMed Web of Science ®Google Scholar
• Sánchez C, Bøgesø KP, Ebert B, et al. Escitalopram versus citalopram: the surprising role of R-enantiomer. Psychopharmacology 2004;174:163–76
   PubMed Web of Science ®Google Scholar
• Li X-Q, Weidolf L, Simonsson R, Andersson TB. Enantiomer/Enantiomer interactions between the S- and R-isomers of omeprazole in human cytochrome P450 enzymes: major role of CYP2C19 and CYP3A4. J Pharmacol Exp Ther 2005;315:777–87
   PubMed Web of Science ®Google Scholar
• Velkov T, Chuang S, Wielens J, et al. The interaction of lipophilic drugs with intestinal fatty acid-binding protein. J Biol Chem 2005;280:17769–76
   PubMed Web of Science ®Google Scholar
• Keskinbora K, Aydınlı I. Atipik opioid analjezik: Tramadol. Ağri 2006;18:5–19
   PubMedGoogle Scholar
• McLean TH, Chambers JJ, Parrish JC, et al. C-(4,5,6-Trimethoxyindan-1-yl)methamine: a mescaline analogue designed using a homology model of the 5-HT2A receptor. J Med Chem 2006;49:4269–74
   PubMed Web of Science ®Google Scholar
• Bingham B, Jones PG, Uveges AJ, et al. Species-specific in vitro pharmacological effects of cannabinoid receptor 2 (CB2) selective ligand AM1241 and its resolved enantiomers. Br J Pharmacol 2007;151:1061–70
   PubMed Web of Science ®Google Scholar
• Hao Z, Zhang Y, Pan L, et al. Comparison of enantiomers of SPFF, a novel β2-adrenoceptor agonist, in bronchodilating effect in Guinea Pigs. Biol Pharm Bull 2008;31:866–72
   PubMed Web of Science ®Google Scholar
• Stresser DM, Mason AK, Perloff ES, et al. Differential time- and NADPH-dependent inhibition of CYP2C19 by enantiomers or fluoxetine. Drug Metab Dispos 2009;37:695–8
   PubMed Web of Science ®Google Scholar
• Weiser MJ, Wu TJ, Handa RJ. Estrogen receptor-β agonist diarylpropionitrile: biological activities of R- and S-enantiomers on behavior and hormonal response to stress. Endocrinology 2009;150:1817–25
   PubMed Web of Science ®Google Scholar
• Maayani S, Weinstein H, Cohen S, Sokolovski M. Acetylcholine-like molecular arrangement in psychomimetic anticholinergic drugs. Proc Natl Acad Sci U S A 1973;70:3103–7
   PubMed Web of Science ®Google Scholar
• Butcher SP, Collins JF, Roberts PJ. Characterization of the binding of DL-[3H]-2-amino-4-phosphonobutyrate to L-glutamate-sensitive sites on rat brain synaptic membranes. Br J Pharmacol 1983;80:355–64
   PubMed Web of Science ®Google Scholar
• Schinazi RF, McMillan A, Cannon D, et al. Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroximethyl)-1,3-oxathiolan-5-yl]cytosine. Antimicrob Agents Chemother 1992;36:2423–31
   PubMed Web of Science ®Google Scholar
• Koizumi T, Saita Y, Miyake A, et al. Antagonistic effect of YM022, an antiulcer agent in rats, on human cholecystokinin (CCK)B/Gastrin receptor. Jpn J Pharmacol 1996;71:307–13
   PubMedGoogle Scholar
• Morrissey I, Hoshino K, Sato K, et al. Mechanism of differential activities of ofloxacin enantiomers. Antimicrob Agents Chemother 1996;40:1775–84
   PubMed Web of Science ®Google Scholar
• Neupert W, Brugger R, Euchenhofer C, et al.  Effects of ibuprofen enantiomers and its coenzyme A thioesters on human prostaglandin endoperoxide synthases. Br J Pharmacol 1997;122:487–92
   PubMed Web of Science ®Google Scholar
• Triggle DJ, Mitchell JM, Filler R. The pharmacology of physostigmine. CNS Drug Rev 1998;4:87–136
   Google Scholar
• Kinney GG, Sur C, Burno M, et al. The glycine transporter type 1 inhibitor N-[3-(4′-fluorophenyl)-3-(4′-phenylphenoxy)propyl]sarcosine potentiates NMDA receptor-mediated responses in vivo and produces and antipsychotic profile in rodent behavior. J Neurosci 2003;23:7586–91
   PubMed Web of Science ®Google Scholar
• Callahan RJ, Au JD, Paul M, et al. Functional inhibition by methadone of N-methyl-D-aspartate receptors expressed in Xenopus oocytes: stereospecific and subunit effects. Anesth Analg 2004;98:653–9
   PubMed Web of Science ®Google Scholar
• Wang L, Wang Y, Zheng J, et al. Pharmacological profiles of an anticholinergic agent, phencynonate hydrochloride, and its optical isomers. Acta Pharmacol Sin 2005;26:527–32
   PubMed Web of Science ®Google Scholar
• Copeland RA. Enzymes: a practical introduction to structure, mechanism and data analysis. New York: John Wiley & Sons, Inc; 2000:282–7
   Google Scholar
• U’Prichard DC, Bylund DB, Snyder SH. (+/−)-[3H]epinephrine and (–)-[3H]dihydroalprenolol binding to β1- and β2-noradrenergic receptor in brain, heart, and lung membranes. J Biol Chem 1978;253:5090–102
   PubMed Web of Science ®Google Scholar
• Tam SW, Cook L. σ opiates and certain antipsychotic drugs mutually inhibit (+)-[3H]SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes. Proc Natl Acad Sci U S A 1984;81:5618–21
   PubMed Web of Science ®Google Scholar
• Panara MR, Greco A, Santini G, et al. Effects of the novel anti-inflammatory compounds, N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulphonamide (NS-398) and 5-methanesulphonamido-6-(2,4-difluorothiophenyl)-1-indanone (L-745,337), on the cyclo-oxygenase activity of human blood prostaglanin endoperoxide synthases. Br J Pharmacol 1995;116:2429–34
   PubMed Web of Science ®Google Scholar
• Damaj MI, Glassco W, Marks MJ, et al. Pharmacological investigation of (+)- and (–)-cis-2,3,3a,4,5,9b-hexahydro-1-methyl-1H-pyrrolo-[3,2-h] isoquinoline, a bridged-nicotine analog. J Pharmacol Exp Ther 1997;282:1425–34
   PubMed Web of Science ®Google Scholar
• Morse KL, Behan J, Laz TM, et al. Cloning and characterization of a novel human histamine receptor. J Pharmacol Exp Ther 2001;296:1058–66
   PubMed Web of Science ®Google Scholar
• Griffin MT, Figueroa KW, Liller S, Ehlert FJ. Estimation of agonist activity at G protein-coupled receptors: analysis of M2 muscarinic receptor signaling through Gi/o, Gs and G15. J Pharmacol Exp Ther 2007;21:1193–207
   Google Scholar
• Yamamoto I, Deniau GP, Gavande N, et al. Agonist responses of (R)- and (S)-3-fluoro-γ-aminobutyric acids suggest an enantiomeric fold for GABA binding to GABAC receptors. Chem Commun 2011;47:7956–8
   PubMed Web of Science ®Google Scholar
• Shannon M, Battaglia G, Glennon RA, Titeler M. 5-HT1 and 5-HT2 binding properties of derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane (2,5-DMA). Eur J Pharmacol 1984;102:23–9
   PubMed Web of Science ®Google Scholar
• Chidlow G, Melena J, Osborne NN. Betaxolol, a β1-adrenoceptor antagonist, reduces Na+ influx into cortical synaptosomes by direct interaction with Na+ channels: comparison with other β-adrenoceptor antagonists. Br J Pharmacol 2000;130:759–66
   PubMed Web of Science ®Google Scholar
• Andersen J, Taboureau O, Hansen KB, et al. Location of the antidepressant binding site in the serotonin transporter. Importance of Ser-438 in recognition of citalopram and tricyclic antidepressants. J Biol Chem 2009;284:10276–84
   PubMed Web of Science ®Google Scholar
• Sinnegger-Brauns MJ, Huber IG, Koschak A, et al. Expression and 1,4-dihydropyridine-binding properties of brain L-type calcium channel isoforms. Mol Pharmacol 2009;75:407–14
   Google Scholar
• Traynelis SF, Wollmuth LP, McBain CJ, et al. Glutamate receptor ion channels: structure, regulation and function. Pharmacol Rev 2010;62:405–96
   PubMed Web of Science ®Google Scholar